CHRONOSCALE CORPORATION (CHRN)
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-11-05
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-11-05
QuarterlyIQ Insights · CHRN
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 278.0% |
| Our one-year growth estimate | diamond | -23.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 301.0 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has been missing across recent quarters and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 28 industry peers · Company calendar date is not available
CHRN — earnings miss
Dated 2026-10-15
of Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, regardless of any general incorporation language in such filing.
Why it matters: Raising capital can help support growth and stabilize finances. Not raising it could limit operations.
Watch forChronoScale announces it raised over $100 million. This helps with cash flow.
Also watch forChronoScale does not secure needed capital. They may announce bad terms for financing.
Why it matters: The company had $15.2 million in cash at quarter end and cites major equipment costs and a need for capital. New funding terms can affect its ability to build.
Worry ifA new filing reports added debt or equity funding, or cash below $15.2 million, while build costs continue.
Less concerning ifA later filing reports cash above $15.2 million with no new debt or equity funding.
Why it matters: Finishing this sale helps ChronoScale focus on its cloud business, which is key for growth.
Supportive ifAnnouncement of the sale's successful completion by the end of Q4 2026.
Worry ifDelays or problems in completing the sale process.
Why it matters: This partnership is key for ChronoScale's infrastructure. Success could lead to more money.
Supportive ifChronoScale says it has finished the 50 MW AI project with Microsoft.
Worry ifThere are delays or issues reported, showing problems in the partnership.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$487 on $10,000 · ±4.9% | How much price usually moves either way. |
| Bad day | $1,125 loss on $10,000 · 11.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,571 loss on $10,000 · 65.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Confirming this revenue target shows strong demand for ChronoScale's AI tools. It shows growth.
Supportive ifChronoScale reports annualized revenue run rate of $1 billion by Q3 2027 in its next earnings call.
Worry ifRevenue run rate falls below $800 million by Q3 2027, indicating weaker demand.
Why it matters: A working 50 MW site would show ChronoScale can deliver a large customer build. Power, equipment, and site work may delay it.
Supportive ifChronoScale or Microsoft reports that the 50 MW site is ready to serve workloads.
Worry ifChronoScale reports a delay, a smaller build, or a missed deployment date for the 50 MW site.
Why it matters: Selling Ekso Bionics helps ChronoScale focus on its cloud business. This could improve financial focus.
Supportive ifChronoScale says the sale of Ekso Bionics is done.
Worry ifManagement delays the sale timeline. They also face challenges in finding a buyer.
Why it matters: Ongoing losses may show deeper problems with managing costs and making money.
Worry ifOperating losses reported worse than -$5.62M in Q2 2026.
Less concerning ifOperating losses improve or stay below -$5.62M in Q3 2026.
Why it matters: Progress on this project shows ChronoScale can grow in AI infrastructure.
Supportive ifA press release confirms the project is on track and will be ready by Q4 2026.
Worry ifThere are delays or problems with the project timeline or execution.
Why it matters: Better margins mean better cost control and efficiency. This is key for long-term success.
Supportive ifGross profit margins improve to above 25% in the next earnings report.
Worry ifGross profit margins are below 20%. This shows ongoing problems in operations.
Why it matters: Raising capital is key for funding operations and growth plans.
Supportive ifThere is news of new financing deals or capital raised over $100 million.
Worry ifNot getting more financing or bad news about current credit agreements.
Why it matters: Getting new money shows management can pay for operations and growth.
Supportive ifA new capital raise over $50 million will be announced through debt or equity.
Worry ifNo new capital raises announced in the next quarter.